NEXIEN BIOPHARMA, INC. Earnings Per Share (Diluted)
NEXIEN BIOPHARMA, INC. reported Earnings Per Share (Diluted) of $0.00 per share for the 3-month period ending 2025-03-31, per its 10-Q filed 2025-05-14.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareDiluted · last filed 2025-05-14
- NEXIEN BIOPHARMA, INC. earnings per share, diluted for the quarter ending 2025-03-31 was $0.00, a 100.00% decline year-over-year.
- NEXIEN BIOPHARMA, INC. earnings per share, diluted for the quarter ending 2024-12-31 was $0.00.
- NEXIEN BIOPHARMA, INC. earnings per share, diluted for the quarter ending 2024-09-30 was $0.00.
- NEXIEN BIOPHARMA, INC. earnings per share, diluted for the quarter ending 2024-06-30 was -$0.00.
- NEXIEN BIOPHARMA, INC. earnings per share, diluted for fiscal 2024 was $0.00.
- NEXIEN BIOPHARMA, INC. earnings per share, diluted for fiscal 2023 was -$0.01.
- NEXIEN BIOPHARMA, INC. earnings per share, diluted for fiscal 2022 was -$0.01.
| Period end | Earnings Per Share, Diluted 3 month | Earnings Per Share, Diluted 3 month as first filed | Earnings Per Share, Diluted 6 month | Earnings Per Share, Diluted 9 month | Earnings Per Share, Diluted 9 month as first filed | Earnings Per Share, Diluted 12 month |
|---|---|---|---|---|---|---|
| 2025-03-31 | $0.00 10-Q · filed 2025-05-14 | -$0.00 derived: net income ÷ weighted average shares · filed 2025-05-14 | $0.00 10-Q · filed 2025-05-14 | -$0.00 derived: net income ÷ weighted average shares · filed 2025-05-14 | ||
| 2024-12-31 | $0.00 10-Q · filed 2025-02-14 | $0.00 10-Q · filed 2025-02-14 | -$0.00 derived: net income ÷ weighted average shares · filed 2025-05-14 | -$0.00 derived: net income ÷ weighted average shares · filed 2025-05-14 | ||
| 2024-09-30 | $0.00 10-Q · filed 2024-11-18 | -$0.00 derived: net income ÷ weighted average shares · filed 2025-05-14 | -$0.00 derived: net income ÷ weighted average shares · filed 2025-05-14 | -$0.00 derived: net income ÷ weighted average shares · filed 2025-05-14 | ||
| 2024-06-30 | -$0.00 derived: net income ÷ weighted average shares · filed 2024-10-22 | -$0.00 derived: net income ÷ weighted average shares · filed 2025-05-14 | -$0.00 derived: net income ÷ weighted average shares · filed 2025-05-14 | $0.00 10-K · filed 2024-10-22 | ||
| 2024-03-31 | $0.00 10-Q · filed 2025-05-14 | -$0.00 10-Q · filed 2024-05-15 | -$0.00 derived: net income ÷ weighted average shares · filed 2025-05-14 | $0.00 10-Q · filed 2025-05-14 | -$0.00 10-Q · filed 2024-05-15 | -$0.00 derived: net income ÷ weighted average shares · filed 2025-05-14 |
| 2023-12-31 | $0.00 10-Q · filed 2025-02-14 | $0.00 10-Q · filed 2025-02-14 | -$0.00 derived: net income ÷ weighted average shares · filed 2025-05-14 | -$0.00 derived: net income ÷ weighted average shares · filed 2025-05-14 | ||
| 2023-09-30 | -$0.00 10-Q · filed 2024-11-18 | -$0.00 derived: net income ÷ weighted average shares · filed 2025-05-14 | -$0.00 derived: net income ÷ weighted average shares · filed 2025-05-14 | -$0.01 derived: net income ÷ weighted average shares · filed 2025-05-14 | ||
| 2023-06-30 | -$0.00 derived: net income ÷ weighted average shares · filed 2024-10-22 | -$0.00 derived: net income ÷ weighted average shares · filed 2024-10-22 | -$0.00 derived: net income ÷ weighted average shares · filed 2024-10-22 | -$0.01 10-K · filed 2024-10-22 | ||
| 2023-03-31 | -$0.00 10-Q · filed 2024-05-15 | -$0.00 derived: net income ÷ weighted average shares · filed 2024-05-15 | -$0.00 10-Q · filed 2024-05-15 | |||
| 2022-12-31 | $0.00 10-Q · filed 2024-02-20 | $0.00 10-Q · filed 2024-02-20 | ||||
| 2022-09-30 | -$0.00 10-Q · filed 2023-11-14 | |||||
| 2022-06-30 | -$0.01 10-K · filed 2023-09-28 |